Commentary

Prevention and treatment of osteoporosis


 

The bottom line

Identify risk factors for osteoporosis in postmenopausal women and men over the age of 50 years. Bone mineral density screening is an important part of fracture prevention, and vertebral imaging should now be considered as a part of osteoporosis screening. Pharmacologic treatment can be considered when a nontraumatic fracture is apparent; if the T score is less than or equal to –2.5; or for individuals with an elevated 10-year fracture risk based on WHO model.

• Source: Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2013.

Dr. Skolnik is associate director of the family medicine residency program at Abington (Pa.) Memorial Hospital and professor of family and community medicine at Temple University, Philadelphia. Dr. Charles is a second year resident in the Family Medicine Residency Program at Abington Memorial Hospital.

Pages

Recommended Reading

New Criteria for Gestational Diabetes Could Swamp Providers
MDedge ObGyn
Diabetes confers 27% increase in breast cancer risk
MDedge ObGyn
Overweight pregnant women can safely gain under 25 pounds
MDedge ObGyn
Metabolic syndrome skews Oncotype DX reliability
MDedge ObGyn
PCOS panel calls for classification, name changes
MDedge ObGyn
Nitrogen-binding agent approved for treating urea cycle disorders
MDedge ObGyn
USPSTF recommends against postmenopausal vitamin D/calcium supplementation
MDedge ObGyn
FDA panel rejects SSRI's approval as a hot flash treatment
MDedge ObGyn
Recommendations for gestational diabetes mellitus screening remain unchanged
MDedge ObGyn
Being postmenopausal doubles hepatic steatosis risk
MDedge ObGyn